Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults
Open Access
- 1 March 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (5), 667-675
- https://doi.org/10.1086/527489
Abstract
Background. Influenza A H5N1 viruses pose a significant threat to human health.Methods. We conducted a multicenter, randomized, double-blind study inKeywords
This publication has 14 references indexed in Scilit:
- Safety and Immunogenicity of Nonadjuvanted and MF59-Adjuvanted Influenza A/H9N2 Vaccine PreparationsClinical Infectious Diseases, 2006
- Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trialThe Lancet, 2006
- Safety and Immunogenicity of an Inactivated Subvirion Influenza A (H5N1) VaccineNew England Journal of Medicine, 2006
- Highly Pathogenic Avian Influenza H5N1, Thailand, 2004Emerging Infectious Diseases, 2005
- From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenzaNature Reviews Microbiology, 2004
- Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccineVirus Research, 2004
- Avian Influenza A (H5N1) in 10 Patients in VietnamNew England Journal of Medicine, 2004
- Comparison of the safety, tolerability, and immunogenicity of a MF59-adjuvanted influenza vaccine and a non-adjuvanted influenza vaccine in non-elderly adultsVaccine, 2003
- MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profileExpert Review of Vaccines, 2003
- Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenzaThe Lancet, 2001